LUKAS SCHEIBLER - 04 Apr 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF INNOVATION OFFICER
Signature
/s/ David Watson, attorney-in-fact for Lukas Scheibler
Issuer symbol
APLS
Transactions as of
04 Apr 2022
Net transactions value
-$151,059
Form type
4
Filing time
05 Apr 2022, 16:08:15 UTC
Previous filing
04 Apr 2022
Next filing
06 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $48,530 +3,504 +6.7% $13.85 55,737 04 Apr 2022 Direct F1
transaction APLS Common Stock Sale $45,677 -818 -1.5% $55.84 54,919 04 Apr 2022 Direct F1, F2
transaction APLS Common Stock Sale $81,714 -1,437 -2.6% $56.86 53,482 04 Apr 2022 Direct F1, F3
transaction APLS Common Stock Sale $72,198 -1,249 -2.3% $57.80 52,233 04 Apr 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -3,504 -6.5% $0.000000 50,000 04 Apr 2022 Common Stock 3,504 $13.85 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise and sale from 10B5-1 trading plan.
F2 The sale price range within $1.00. Max. $55.21 - Min. $56.13
F3 The sale price range within $1.00. Max. $56.34 - Min. $57.22
F4 The sale price range within $1.00. Max. $57.37 - Min. $58.29.
F5 This represents a stock option grant made on 02/08/2019 that vests as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to the satisfaction of a specified performance condition and continued service.